IQVIA艾昆纬：2024年EFPIA患者W.A.1.T.指标调查报告（英文版）

The Patients W.A.I.T. (Waiting to Access Innovative Therapies) Indicator has been running in evolving formats since 2004 and has offered a comprehensive overview of public reimbursement across over 30 countries since 2018. However, the relevance of whether an innovative molecule is included on public reimbursement lists has diminished over the years, with a rise in patient access through alternative channels and/or with restrictions. This year’s iteration of the report retains the core availa